LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...
Source: prnewswire.com